Pulmonary Services

Pulmonary Hypertension & Pulmonary Vascular Diseases Program

Penn State Milton S. Hershey Medical Center now offers world-class care for patients with pulmonary hypertension and pulmonary vascular diseases through a comprehensive, multidisciplinary program. The team includes dedicated pulmonologists, cardiologists, interventional radiologists, and specialty nurses.

Services Offered

  • Prompt diagnostic evaluation by a pulmonologist and follow up by a cardiologist, if needed.
  • Diagnostic testing including right heart catheterization, acute vasoreactivity testing, stress echocardiography, and cardiopulmonary exercise testing.
  • Full range of conventional and new therapies for pulmonary arterial hypertension including endothelin receptors antagonists, phosphodiestrase inhibitors, intravenous, and inhaled prostacyclin analogues.

Who May Benefit?

  • High pulmonary artery pressure on echocardiogram or heart catheterization with suspected pulmonary arterial hypertension (PAH).
  • Idiopathic pulmonary arterial hypertension (iPAH).
  • PAH associated with:
    • Rheumatological disorders, e.g. SLE, scleroderma
    • Adult congenital heart disease
    • Advanced liver disease and portal hypertension
    • Appetite suppressant use in past
    • Pulmonary thromboembolic disease
    • Sickle cell disease, HIV, sarcoidosis, pulmonary, veno-occlusive disease, and others.
  • Dyspnea not fully explained by pulmonary function testing or chest imaging, in the absence of suspected cardiac or neuromuscular diseases.
  • Complicated chronic thromboembolic disease.
  • Other pulmonary vascular diseases, e.g. symptomatic mediastinal fibrosis etc.

For more information or to schedule an appointment please call the MD Network at 1-800-233-4082.

Telephone consultations are welcomed.  Call Robert Vender, M.D., at 717-531-6525.

  • Prompt diagnostic evaluation by a pulmonologist and follow up by a cardiologist, if needed.
  • Diagnostic testing including right heart catheterization, acute vasoreactivity testing, stress echocardiography, and cardiopulmonary exercise testing.
  • Full range of conventional and new therapies for pulmonary arterial hypertension including endothelin receptors antagonists, phosphodiestrase inhibitors, intravenous, and inhaled prostacyclin analogues.